A complete application in a minute
Tailored resume and cover letter, ready to send.
Zealand Pharma is seeking a Senior Principal Scientist to lead small molecule medicinal chemistry within our Discovery Research team.
You will guide cross-functional teams on design, optimization, and profiling of novel candidates and drive their progression from lead identification to preclinical development.
Do you know what it takes to advance a small molecule preclinical asset into clinical development, and do you also have a keen interest in expanding your horizon into peptide drug discovery? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
As a Senior Principal Scientist or Principal Scientist, you will join our Discovery Research team at the most exciting time for the company, acting as the company anchor in external collaborations with partners on small molecule assets. You will take an active role in global, cross-organizational project teams, providing input to compound design and securing fast progress of suitable lead candidates within obesity, rare diseases, and chronic inflammation.
Working closely with colleagues across medicinal chemistry, computational chemistry, in vitro/in vivo pharmacology, and ADME, you will bring a broad drug discovery understanding and mindset to everything you do.
We offer exciting responsibilities:
You bring deep expertise in small molecule drug discovery and a proven track record designing and optimizing small molecule-based therapeutics within a pharmaceutical setting. You combine strong scientific judgment with the ability to lead and influence across cross-functional teams and external collaborations, and you’re motivated to broaden your scope toward peptide drug discovery as Zealand Pharma builds on its core focus area.
You will join the Medicinal & Computational Chemistry team, a mix of scientists at varying levels of experience and laboratory technicians, working together to drive structure-based and computational approaches across our drug discovery pipeline.
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold.
For further information, please contact Head of Medicinal & Computational Chemistry, Magnus Bernt Fredrik Gustafsson and MGustafsson@zealandpharma.com.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.